Mucormycosis-induced ileocecal perforation: A case report and review of literature
Poyuran, R, Dharan, B, Sandhyamani, S, Narasimhaiah, D
Published in Journal of postgraduate medicine (01.01.2020)
Published in Journal of postgraduate medicine (01.01.2020)
Get full text
Journal Article
1194MO Canakinumab (CAN) + docetaxel (DTX) for the second- or third-line (2/3L) treatment of advanced non-small cell lung cancer (NSCLC): CANOPY-2 phase III results
Paz-Ares, L., Goto, Y., Lim, W.D.T., Halmos, B., Cho, B.C., Dols, M. Cobo, Gonzalez-Larriba, J.L., Zhou, C., Demedts, I., Atmaca, A., Baka, S., Mookerjee, B.P., Portella, S., Zhu, Z., Dharan, B., Reck, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Ventricular dysfunction after permanent pacemaker implantation in children - what are the implications?
Bhattacharya, D, Namboodiri, N, Nair, K K M, Dharan, B S
Published in European heart journal (09.11.2023)
Published in European heart journal (09.11.2023)
Get full text
Journal Article
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
Massacesi, Cristian, Di Tomaso, Emmanuelle, Urban, Patrick, Germa, Caroline, Quadt, Cornelia, Trandafir, Lucia, Aimone, Paola, Fretault, Nathalie, Dharan, Bharani, Tavorath, Ranjana, Hirawat, Samit
Published in OncoTargets and therapy (01.01.2016)
Published in OncoTargets and therapy (01.01.2016)
Get full text
Journal Article
Abstract OT2-3-08: Phase III randomized study of the oral pan-PI3K inhibitor BKM120 with fulvestrant in postmenopausal women with HR+/HER2– locally advanced or metastatic breast cancer, treated with aromatase inhibitor, and progressed on or after mTOR inhibitor-based treatment – BELLE-3
Di Leo, A, Germa, C, Weber, D, Di Tomaso, E, Dharan, B, Massacesi, C, Hirawat, S
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract S4-07: BELLE-3: A phase III study of buparlisib + fulvestrant in postmenopausal women with HR+, HER2–, aromatase inhibitor-treated, locally advanced or metastatic breast cancer, who progressed on or after mTOR inhibitor-based treatment
Di Leo, A, Seok Lee, K, Ciruelos, E, Lønning, P, Janni, W, O'Regan, R, Mouret Reynier, M-A, Kalev, D, Egle, D, Csoszi, T, Bordonaro, R, Decker, T, Tjan-Heijnen, VC, Blau, S, Schirone, A, Weber, D, El-Hashimy, M, Dharan, B, Sellami, D, Bachelot, T
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer
RAMLAU, Rodryg, GERVAIS, Radj, SHEPHERD, Frances A, KRZAKOWSKI, Maciej, VON PAWEL, Joachim, KAUKEL, Eckhard, ABRATT, Raymond P, DHARAN, Bernie, GROTZINGER, Kelly M, ROSS, Graham, DANE, Graham
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program
Castro-Malaspina, Hugo, Harris, Richard E., Gajewski, James, Ramsay, Norma, Collins, Robert, Dharan, Bernie, King, Roberta, Deeg, H. Joachim
Published in Blood (15.03.2002)
Published in Blood (15.03.2002)
Get full text
Journal Article
Phase II study of oral topotecan plus bevacizumab (topo-bev) for second-line treatment of small cell lung cancer (SCLC)
Waterhouse, D. M., Morgan, S. K., Spigel, D. R., Shankar, S., Dharan, B., Foose, D. E., Bhatt, K.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A global phase II, single-arm, open-label study to determine the efficacy of midostaurin in patients with aggressive systemic mastocytosis (ASM) or mast cell leukemia (MCL) with or without an associated hematologic clonal nonmast cell lineage disease (AHNMD)
Gotlib, J. R., Kluin-Nelemans, H., Mauro, M. J., Hermine, O., Hexner, E. O., Lipton, J. H., Awan, F. T., Nikolova, Z. G., Gross, S. H., Dutreix, C., Dharan, B., George, T., Horny, P., Akin, C., Hartmann, K., Valent, P., Reiter, A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
An open-label, single arm, phase II study of IV weekly (days 1 and 8) topotecan in combination with carboplatin (day 1) every 21 days as second-line therapy in subjects with platinum-sensitive relapsed ovarian cancer: First stage results
Schwartz, P. E., Rose, P. G., Monk, B. J., Provencher, D., Dharan, B., Legenne, P., Sherman, L. J.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Is symptom improvement in patients with small cell lung cancer (SCLC) associated with clinical response? An analysis using the Patient Symptom Assessment Lung Cancer (PSALC) scale in a randomized trial comparing oral topotecan (OT) with best supportive care (BSC)
O'Brien, M. E., Duh, M., Chen, L., Antras, L., Neary, M., Dharan, B., Gralla, R. J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Symptom assessment in small cell lung cancer (SCLC) in a randomized trial: A psychometric analysis of Patient Symptom Assessment in Lung Cancer (PSALC)
Chen, L., Antras, L., Duh, M., Neary, M., Dharan, B., O’Brien, M. E.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
A physician-reported neurological signs and symptoms worksheet (NSS WS) in EGF105084: A phase II study of lapatinib (lap) for pts with recurrent brain metastases (BM) from HER2+ breast cancer (BC)
Lin, N. U., Roché, H. H., Dieras, V., Skarlos, D., Stemmler, H. J., Liu, M., Dharan, B., Zembryki, D., Stepewski, K., Rubin, S. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
Eckardt, J. R., Ramlau, R., Gervais, R., Shepherd, F., O’Brien, M., Ciuleanu, T., Dharan, B., Wissel, P., Ross, G.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article